1701 related articles for article (PubMed ID: 20094046)
1. Fibroblast growth factor signalling: from development to cancer.
Turner N; Grose R
Nat Rev Cancer; 2010 Feb; 10(2):116-29. PubMed ID: 20094046
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated FGF signalling in neoplastic disorders.
Tanner Y; Grose RP
Semin Cell Dev Biol; 2016 May; 53():126-35. PubMed ID: 26463732
[TBL] [Abstract][Full Text] [Related]
3. FGF signalling in prostate development, tissue homoeostasis and tumorigenesis.
Lin Y; Wang F
Biosci Rep; 2010 Apr; 30(5):285-91. PubMed ID: 20406196
[TBL] [Abstract][Full Text] [Related]
4. Advances and challenges in targeting FGFR signalling in cancer.
Babina IS; Turner NC
Nat Rev Cancer; 2017 May; 17(5):318-332. PubMed ID: 28303906
[TBL] [Abstract][Full Text] [Related]
5. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
Dianat-Moghadam H; Teimoori-Toolabi L
Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
[TBL] [Abstract][Full Text] [Related]
6. Targeting the fibroblast growth factor receptor family in cancer.
Hallinan N; Finn S; Cuffe S; Rafee S; O'Byrne K; Gately K
Cancer Treat Rev; 2016 May; 46():51-62. PubMed ID: 27109926
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of FGFR-mediated carcinogenesis.
Ahmad I; Iwata T; Leung HY
Biochim Biophys Acta; 2012 Apr; 1823(4):850-60. PubMed ID: 22273505
[TBL] [Abstract][Full Text] [Related]
8. Non-canonical fibroblast growth factor signalling in angiogenesis.
Murakami M; Elfenbein A; Simons M
Cardiovasc Res; 2008 May; 78(2):223-31. PubMed ID: 18056763
[TBL] [Abstract][Full Text] [Related]
9. The role of fibroblast growth factors and their receptors in prostate cancer.
Kwabi-Addo B; Ozen M; Ittmann M
Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Structural and Functional Diversity among FGF Signals: A Comparative Study of Human, Mouse, and Xenopus FGF Ligands in Embryonic Development and Cancer Pathogenesis.
Goutam RS; Kumar V; Lee U; Kim J
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108717
[TBL] [Abstract][Full Text] [Related]
11. Future applications of FGF/FGFR inhibitors in cancer.
Ghedini GC; Ronca R; Presta M; Giacomini A
Expert Rev Anticancer Ther; 2018 Sep; 18(9):861-872. PubMed ID: 29936878
[TBL] [Abstract][Full Text] [Related]
12. Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction.
Carter EP; Fearon AE; Grose RP
Trends Cell Biol; 2015 Apr; 25(4):221-33. PubMed ID: 25467007
[TBL] [Abstract][Full Text] [Related]
13. De-regulated FGF receptors as therapeutic targets in cancer.
Knights V; Cook SJ
Pharmacol Ther; 2010 Jan; 125(1):105-17. PubMed ID: 19874848
[TBL] [Abstract][Full Text] [Related]
14. The role of fibroblast growth factors in tumor growth.
Korc M; Friesel RE
Curr Cancer Drug Targets; 2009 Aug; 9(5):639-51. PubMed ID: 19508171
[TBL] [Abstract][Full Text] [Related]
15. Distinct fibroblast growth factor (FGF)/FGF receptor signaling pairs initiate diverse cellular responses in the oligodendrocyte lineage.
Fortin D; Rom E; Sun H; Yayon A; Bansal R
J Neurosci; 2005 Aug; 25(32):7470-9. PubMed ID: 16093398
[TBL] [Abstract][Full Text] [Related]
16. Small molecule inhibition of fibroblast growth factor receptors in cancer.
Liang G; Chen G; Wei X; Zhao Y; Li X
Cytokine Growth Factor Rev; 2013 Oct; 24(5):467-75. PubMed ID: 23830577
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase signalling in breast cancer: fibroblast growth factors and their receptors.
Dickson C; Spencer-Dene B; Dillon C; Fantl V
Breast Cancer Res; 2000; 2(3):191-6. PubMed ID: 11250709
[TBL] [Abstract][Full Text] [Related]
18. The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention.
Mahapatra S; Jonniya NA; Koirala S; Ursal KD; Kar P
J Biomol Struct Dyn; 2023; 41(22):13509-13533. PubMed ID: 36995019
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid orchestrates fibroblast growth factor signalling to drive embryonic stem cell differentiation.
Stavridis MP; Collins BJ; Storey KG
Development; 2010 Mar; 137(6):881-90. PubMed ID: 20179094
[TBL] [Abstract][Full Text] [Related]
20. Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy.
Giacomini A; Chiodelli P; Matarazzo S; Rusnati M; Presta M; Ronca R
Pharmacol Res; 2016 May; 107():172-185. PubMed ID: 27013279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
